EUVIMEDEUVIMED entdecken
Open Access

Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders

Maria Pagoni, Vasileios L Zogopoulos, Stavros Kontogiannis, Annia Tsolakou, Vassilios Zoumpourlis, George Th Tsangaris, Eleftherios Fokaefs, Ioannis Michalopoulos, Aristidis M Tsatsakis, Nikolaos Drakoulis

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Maria Pagoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Metabolic Diseases, Prostatic Hyperplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMetabolic DiseasesProstatic HyperplasiaMaleHumansAgedMiddle AgedMicroRNAsPharmacogeneticsCohort Studies

Stichwörter der Autor:innen

BPHCYP3A4FoxO signaling pathwayPCaPharmacogeneticsdiabetesdislipidemiaepigeneticsestrogen signaling pathwayhypertensionmetabolomicsmiRNAsp53 signaling pathwayprostatic neoplasiasteroid hormone pathway

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece; maria.pagoni@pharm.uoa.gr gthtsangaris@bioaca…
  • Centre of Systems Biology, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
  • Department of Urology, Patras University Hospital, Patras, Greece.
  • Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
  • National Hellenic Research Foundation, Athens, Greece.
  • Proteomics Research Unit, Biomedical Research Foundation, Academy of Athens, Athens, Greece; maria.pagoni@pharm.uoa.gr gthtsangaris@bioacademy.gr.

Zitieren

APA

Pagoni, M., Zogopoulos, V. L., Kontogiannis, S., Tsolakou, A., Zoumpourlis, V., Tsangaris, G. T., Fokaefs, E., Michalopoulos, I., Tsatsakis, A. M., & Drakoulis, N. (2025). Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20502

Vancouver

Pagoni M, Zogopoulos VL, Kontogiannis S, Tsolakou A, Zoumpourlis V, Tsangaris GT, et al. Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20502

BibTeX
@article{Pagoni2025,
  author = {Pagoni, Maria and Zogopoulos, Vasileios L and Kontogiannis, Stavros and Tsolakou, Annia and Zoumpourlis, Vassilios and Tsangaris, George Th and Fokaefs, Eleftherios and Michalopoulos, Ioannis and Tsatsakis, Aristidis M and Drakoulis, Nikolaos},
  title = {Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20502}
}
Kostenlos starten →